Insulin resistance is one of the most common metabolic conditions in the world — and one of the least understood by the people who have it. It sits at the center of a web of conditions that GLP-1 therapy directly addresses.
Insulin is a hormone produced by the pancreas that acts as a 'key' to allow glucose (blood sugar) into cells for energy. When you eat carbohydrates, blood glucose rises, insulin is released, and cells absorb the glucose. This is how it's supposed to work.
When cells become insulin resistant, they no longer respond well to insulin's signal. The pancreas compensates by producing more and more insulin. Eventually, blood sugar starts to rise anyway — first as prediabetes, then type 2 diabetes if untreated.
GLP-1 medications improve insulin sensitivity through multiple pathways: reducing visceral fat, slowing glucose absorption, stimulating insulin release only when glucose is elevated (glucose-dependent), and reducing inflammation. This is why the metabolic benefits of GLP-1 extend far beyond the number on the scale.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.